United States · Series F startup
Funding summaryUpdated 26 Oct 2026
$379Mraised across 3 rounds since 2019, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Source recorded
Venrock
ARCH Venture Partners
Illumina Ventures
Altitude Life Science VenturesReported by Prnewswire
From Encoded Therapeutics's own website: 1 founder, 6 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
This firm lists Encoded Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Encoded Therapeutics's investors include Venrock, ARCH Venture Partners, Menlo Ventures, Illumina Ventures and Janus Henderson Investors, and 4 more on record.
Encoded Therapeutics has raised $379M across 3 rounds since 2019. One round did not disclose an amount, so the total is a floor.
Encoded Therapeutics's most recent round was a Series F of $275M in Sept 2026.
Its most recent round, $275M in Sept 2026, is also its largest on record.
Encoded Therapeutics's first round on record, in Jun 2019, was backed by Venrock, ARCH Venture Partners and Illumina Ventures and 2 others.
Encoded Therapeutics's latest named round is a Series F, in Sept 2026.
Encoded Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
